Navigation Links
DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger
Date:3/16/2010

HENDERSON, NV, March 16 /PRNewswire-FirstCall/ - DDS Technologies USA, Inc. (DDSU; www.ddstechnologiesusa.com) had retained the Mina Mar Group (http://www.minamargroup.com/) as forefront representative of the company's new expansive corporate interests.

Mina Mar Group will lead the company as its head Merger Corporate Advisor, and its peer company Mina Mar Marketing Group (www.minamargroup.net) will take over the Investor Relations (IR) tasks. The mandate is to represent DDSU's interests in public market and bring the company closer to the investors' community.

A source close to the company said, "We remind our followers that DDSU operates under the auspices of the court appointed guardian-custodian. We have posted court documents on our corporate web site www.ddstechnologiesusa.com, and our IR web site, "NEWS AND FILINGS" section, and www.minamargroup.com/ddsu.pdf . We ask our followers to review these court documents.

Regarding the upcoming merger the company reminds its followers that the only currency the company has, are its restricted shares, and cash in a form of a loan or financing from its preferred shareholders or accredited investors. Usual process in the merger is that a company will recapitalize to absorb the mergers, and pay for the acquired assets. Depending on the situation, sometimes both cash and shares are issued in the merger. Obviously, the higher the share price of our stock the less stock the company has to issue in the merger to the targeted merger company.

As this merger is being created, these new shares will be held in escrow, and remain the control block for some time after the merger. The shares these companies receive are subject to insiders and control block, referred to as Rule 144. These are restricted shares, meaning they cannot trade; henceforth both float and the free trading shares usually remain undisturbed after the merger.

The company will shortly begin subscribing to Pink Sheets filing service and begin updating Pink Sheets with Adequate Disclosure, Updated Financials and report all relevant merger news. There is no reverse split, nor any toxic financing planned for the company. The company has made available sufficient funds and resources through its preferred shareholders and accredited investors to become a vibrant and operational company.

Immediate plans include bringing representatives and CEOs from the targeted merger companies to the Mina Mar Group Shareholders' Conference on April 9, 2010 in Toronto for further discussion, and a possible finalization of the merger transaction shortly thereafter. Again, merger transactions are a process and subject to change.

The company reminds our shareholders and followers to monitor PinkSheets.com Filing Section and also our IR company web site section "PRESS RELEASES AND FILINGS" TAB http://www.minamargroup.net/ for non news worthy corporate updates.

For any matters relating to retail investor queries or to send IR or the company a message please click on the "INVESTOR SUPPORT" TAB or this direct link http://www.minamargroup.net/helpdesk.

Don't be a victim. Report a stock basher. The company is mindful that short sellers, the company competitors and stock bashers stalk small cap Pink Sheets listed companies with hidden agendas. Visit http://www.stockbasher.com/ and find out what criminal and civil actions the US authorities are taking against web sites like investorshub.com and other posters, and the remedies available to you as an individual investor.

Filings for this event are currently being reviewed and will be filed with Pink Sheets and Client Support Section in due course. To be included in company's email database for press releases, industry updates, and non-weekly activity at the company that may or may not be news released, please subscribe or opt in mailer at http://www.minamargroup.com/updates.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of DDS Technologies USA, Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be", "expects", "may affect", "believed", "estimate", "project" and similar words and phrases are intended to identify such forward-looking statements. DDS Technologies USA, Inc. cautions you that any forward-looking information provided by or on behalf of DDS Technologies USA, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. DDS Technologies USA, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond DDS Technologies USA, Inc.'s control. In addition to those discussed in DDS Technologies USA, Inc.'s press releases, public filings, and statements by DDS Technologies USA, Inc.'s management, including, but not limited to, DDS Technologies USA, Inc.'s estimate of the sufficiency of its existing capital resources, DDS Technologies USA, Inc.'s ability to raise additional capital to fund future operations, DDS Technologies USA, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match DDS Technologies USA, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. DDS Technologies USA, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For any investor relations matters, please contact www.minamargroup.net/helpdesk; Investor Relations Department Inquiry, www.minamargroup.net (IR); For (M&A) and Corporate Matters,www.minamargroup.com

SOURCE DDS Technologies USA, Inc.

Back to top
'/>"/>
SOURCE DDS Technologies USA, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
2. Netsmart Technologies Selected by Douglas Gardens Community Mental Health to Provide Behavioral Health Software Solution
3. China Medical Technologies Reports Third Fiscal Quarter Financial Results
4. Doctors and First Responders Rely on Oberthur Technologies in Times of Emergency
5. Fortrex Technologies Achieves HITRUST Common Security Framework Assessor Status
6. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
7. iCorps Technologies Earns CompTIA Security Trustmark™
8. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on February 16, 2010
9. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
10. China Medical Technologies to Participate Investor Conferences in March 2010
11. Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 ... better understand Enzo Biochem and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017  The National ... has joined the health policy research organization as its ... Medical and Regulatory Affairs ( North America ... Board of Directors. "We,re pleased to have ... NPC President Dan Leonard . "We welcome their ...
(Date:3/28/2017)... March 28, 2017 Biostage, Inc. ... developing bioengineered organ implants to treat cancers and other ... announced that Jim McGorry, CEO of Biostage, ... panel at the MassBio 2017 Annual Meeting ... ET in Cambrige, Massachussetts. The 3D Printing and ...
(Date:3/28/2017)... March 28, 2017 Focus ... unpredictable sector due to the scientifically intensive operations ... medical, agricultural, environmental, and industrial. In today,s pre-market research, ... Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: OVAS), ... Inc. (NASDAQ: OCUL ). Learn more ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
Breaking Biology News(10 mins):